New-Onset Vitiligo During Treatment with Secukinumab: Report of Two Cases and Review of the Literature
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s40261-020-00964-w.pdf
Reference10 articles.
1. Bae JM, Lee JH, Yun JS, Han B, Young HT. Vitiligo and overt thyroid diseases: a nationwide population-based study in Korea. J Am Acad Dermatol. 2017;76(5):871–8. https://doi.org/10.1016/j.jaad.2016.12.034.
2. Méry-Bossard L, Bagny K, Chaby G, Khemis A, Maccari F, Marotte H, Perrot JL, Reguiai Z, Sigal ML, Avenel-Audran M, Boyé T, Grasland A, Gillard J, Jullien D, Toussirot E. New-onset vitiligo and progression of pre-existing vitiligo during treatment with biological agents in chronic inflammatory diseases. J Eur Acad Dermatol Venereol. 2017;31(1):181–6. https://doi.org/10.1111/jdv.13759.
3. Mylonas A, Conrad C. Psoriasis: classical vs. paradoxical. The Ying-Yang of TNF and type I interferon. Front Immunol. 2018;9:2746. https://doi.org/10.3389/fimmu.2018.02746.
4. Bae JM, Kim M, Lee HH, Kim KJ, Shin H, Ju HJ, Kim GM, Park CJ, Park HJ. Increased risk of vitiligo following anti-tumor necrosis factor therapy: a 10-year population-based cohort study. J Investig Dermatol. 2018;138(4):768–74. https://doi.org/10.1016/j.jid.2017.11.012.
5. Munera-Campos M, Ballesca F, Carrascoa JM. Paradoxical reactions to biologic therapy in psoriasis: a review of the literature. Actas Dermosifiliogr. 2018;109(9):791–800. https://doi.org/10.1016/j.ad2018.04.003.
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Role of Cytokines and Chemokines in Vitiligo and Their Therapeutic Implications;Journal of Clinical Medicine;2024-08-20
2. A narrative review of the literature: The role of biologics and JAK inhibitors in vitiligo;Australasian Journal of Dermatology;2024-08
3. Guselkumab-induced vitiligo in a patient with psoriatic arthritis;JAAD Case Reports;2023-11
4. Progression of Pre-Existing Vitiligo during Secukinumab Treatment for Psoriasis;Annals of Dermatology;2023
5. Secukinumab-induced vitiligo: A new case report and review of the literature;Therapies;2022-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3